Abstract | OBJECTIVE: METHODS: It was a prospective, open, comparative, multicentric study. 776 children (Mean age 10 years) with LRTIs were included and randomly allotted to two groups respectively. A total of 396 children were given cefpodoxime susp 5 mg/kg b.i.d. and 380 patients on cefixime 4 mg/kg b.i.d. for 10-14 days. RESULTS: CONCLUSION:
Cefpodoxime has been found to be a well-tolerated and superior alternative to cefixime synergistically documenting the extended spectrum of activity.
|
Authors | Jayati Sengupta, A K Mondal, Piyush Jain, R D Garg, N C Mathur, A K Moharana |
Journal | Indian journal of pediatrics
(Indian J Pediatr)
Vol. 71
Issue 6
Pg. 517-21
(Jun 2004)
ISSN: 0019-5456 [Print] India |
PMID | 15226561
(Publication Type: Clinical Trial, Comparative Study, Journal Article, Multicenter Study, Randomized Controlled Trial)
|
Chemical References |
- Anti-Bacterial Agents
- cefpodoxime
- Cefixime
- Ceftizoxime
|
Topics |
- Acute Disease
- Anti-Bacterial Agents
(adverse effects, therapeutic use)
- Cefixime
(adverse effects, therapeutic use)
- Ceftizoxime
(adverse effects, analogs & derivatives, therapeutic use)
- Child
- Child, Preschool
- Female
- Humans
- India
- Infant
- Male
- Prospective Studies
- Respiratory Tract Infections
(drug therapy)
- Treatment Outcome
|